AU
UK
CA
NZ
IND
US
Last update at 2025-07-17T13:11:28.076885Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
CompuGroup Medical SE & Co KgaA (WBO:COP) Q1 2025 Earnings Call Highlights: Navigating ...
Thu 01 May 25, 07:03 AMCompuGroup Medical SE & Co KgaA (CMPUY) Q4 2024 Earnings Call Highlights: Navigating ...
Fri 07 Mar 25, 07:03 AMShould You Be Concerned About CompuGroup Medical SE & Co. KGaA's (ETR:COP) ROE?
Tue 27 Aug 24, 06:56 AMCompuGroup Medical SE KGaA Second Quarter 2024 Earnings: EPS: €0.27 (vs €0.60 in 2Q 2023)
Wed 17 Jul 24, 04:00 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 106.82M | 97.87M | 110.43M | 107.75M | 128.75M |
| Minority interest | -0.70600M | -0.06200M | 0.27M | 0.81M | 2.11M |
| Net income | 73.41M | 68.97M | 73.19M | 65.82M | 92.34M |
| Selling general administrative | 44.97M | 46.24M | 36.32M | 37.16M | 30.73M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 958.16M | 871.19M | 712.95M | 631.42M | 584.11M |
| Reconciled depreciation | 112.32M | 110.71M | 75.71M | 62.86M | 44.60M |
| Ebit | 94.49M | 106.63M | 120.19M | 115.95M | 141.65M |
| Ebitda | 228.25M | 213.99M | 191.56M | 174.92M | 179.76M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | 107.46M | 107.90M | 121.96M | 111.85M | 136.53M |
| Other operating expenses | 183.39M | 144.21M | 126.97M | 103.68M | 100.66M |
| Interest expense | 9.12M | 5.40M | 5.43M | 4.32M | 6.41M |
| Tax provision | 32.70M | 28.84M | 37.01M | 41.59M | 36.16M |
| Interest income | 20.00M | 3.60M | 1.52M | 0.89M | 0.06M |
| Net interest income | 7.05M | -4.44400M | -6.14200M | -5.91000M | -5.00300M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 32.70M | 28.84M | 37.01M | 41.59M | 37.76M |
| Total revenue | 1129.74M | 1025.32M | 837.26M | 745.81M | 717.02M |
| Total operating expenses | 1022.28M | 917.42M | 715.30M | 633.96M | 580.49M |
| Cost of revenue | 171.58M | 154.13M | 124.31M | 114.39M | 132.92M |
| Total other income expense net | - | - | - | - | - |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 74.12M | 69.03M | 73.42M | 66.15M | 92.59M |
| Net income applicable to common shares | 73.41M | 68.97M | 73.19M | 65.82M | 96.08M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 1899.94M | 1944.44M | 1790.81M | 1565.77M | 1065.86M |
| Intangible assets | 625.76M | 654.75M | 625.94M | 545.66M | 337.42M |
| Earning assets | - | - | - | - | - |
| Other current assets | 2.37M | 4.72M | 4.41M | 3.43M | 4.43M |
| Total liab | 1230.67M | 1270.62M | 1178.53M | 926.84M | 805.95M |
| Total stockholder equity | 667.68M | 672.42M | 612.07M | 638.67M | 259.11M |
| Deferred long term liab | - | 1.20M | 1.20M | 1.20M | 1.20M |
| Other current liab | 7.91M | 139.91M | 125.13M | 108.26M | 78.75M |
| Common stock | - | 53.73M | 53.73M | 53.73M | 53.22M |
| Capital stock | 53.73M | 53.73M | 53.73M | 53.73M | 53.22M |
| Retained earnings | - | - | - | - | - |
| Other liab | - | 161.98M | 154.56M | 138.11M | 116.70M |
| Good will | 684.10M | 639.16M | 588.41M | 542.45M | 330.90M |
| Other assets | - | 24.89M | 35.48M | 32.99M | 32.24M |
| Cash | 64.41M | 90.46M | 107.29M | 74.61M | 43.78M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 346.83M | 375.47M | 398.35M | 290.54M | 236.30M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 646.10M | 642.66M | 576.80M | 435.37M | 423.89M |
| Short term debt | - | - | - | - | - |
| Short long term debt | 6.25M | 33.70M | 97.01M | 39.77M | 43.22M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | - | 723.89M | 657.13M | 584.93M | 292.21M |
| Property plant equipment | - | 160.89M | 158.00M | 136.29M | 131.25M |
| Total current assets | 369.83M | 420.81M | 370.78M | 308.11M | 232.93M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | -618.41700M | -599.28500M | -447.07300M | -407.93300M |
| Short term investments | 0.15M | 0.55M | 0.34M | 1.00M | 0.94M |
| Net receivables | 175.46M | 277.46M | 221.06M | 194.47M | 142.49M |
| Long term debt | 704.25M | 699.42M | 587.08M | 470.20M | 424.45M |
| Inventory | 18.88M | 29.44M | 20.64M | 18.16M | 27.49M |
| Accounts payable | 93.01M | 109.14M | 93.19M | 64.52M | 47.09M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1.70M | 1.20M | 1.20M | 1.20M | 1.20M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1530.11M | 1523.63M | 1420.04M | 1257.66M | 832.93M |
| Capital lease obligations | 56.44M | 53.34M | 57.22M | 44.56M | 43.12M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -4.63100M | -6.05300M | -2.02700M | -2.02700M | -2.02700M |
| Change to liabilities | 5.19M | 30.57M | 7.32M | 2.45M | -7.83800M |
| Total cashflows from investing activities | -145.41400M | -163.97600M | -457.11600M | -139.44400M | -47.48000M |
| Net borrowings | 19.06M | 152.79M | 24.85M | 117.92M | -50.90700M |
| Total cash from financing activities | -16.35900M | 30.15M | 338.07M | 49.68M | -93.41000M |
| Change to operating activities | 7.01M | 4.44M | 2.79M | -16.82900M | 6.49M |
| Net income | 73.41M | 68.97M | 73.19M | 65.82M | 96.08M |
| Change in cash | -16.82600M | 31.43M | 29.56M | 21.05M | -5.06000M |
| Begin period cash flow | 107.34M | 75.91M | 46.35M | 25.30M | 30.36M |
| End period cash flow | 90.52M | 107.34M | 75.91M | 46.35M | 25.30M |
| Total cash from operating activities | 145.03M | 165.27M | 149.93M | 110.50M | 136.35M |
| Issuance of capital stock | - | 0.00000M | 337.99M | - | - |
| Depreciation | 78.93M | 75.83M | 55.59M | 44.67M | 26.07M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | -26.11700M | -26.36700M | -24.20600M | -24.41400M | 17.40M |
| Change to inventory | -8.78800M | -2.28000M | 9.49M | -6.23700M | -7.07100M |
| Change to account receivables | -28.76100M | -7.70300M | -34.82300M | 6.62M | -4.62100M |
| Sale purchase of stock | -9.10900M | -96.09600M | 0.00000M | -41.06300M | -24.96700M |
| Other cashflows from financing activities | -0.19200M | -0.17900M | -0.56200M | -2.76400M | -0.13300M |
| Change to netincome | 2.81M | -19.27100M | 13.14M | 7.14M | 13.75M |
| Capital expenditures | 25.85M | 27.05M | 17.68M | 14.68M | 12.73M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -43.17200M | 4.38M | -12.10900M | -24.07300M | -15.21700M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | 4.56M | -5.34700M | 3.40M | -3.64900M | 11.97M |
| Free cash flow | 63.99M | 87.78M | 92.17M | 66.75M | 96.00M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CMPUY CompuGroup Medical SE & Co. KGaA |
- -% | - | 35.00 | - | 1.00 | 1.29 | 1.39 | 8.05 |
| VEEV Veeva Systems Inc Class A |
-0.14 0.09% | 153.16 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 8.55 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
0.18 3.58% | 5.21 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
| BTSG BrightSpring Health Services, Inc. Common Stock |
0.95 1.43% | 67.20 | 100.22 | 40.65 | 0.69 | 4.92 | 0.92 | 25.80 |
CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany.
Maria Trost 21, Koblenz, Germany, 56070
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Rauch L.L.M., M.B.A. | CFO, MD & Member of Management Board | 1972 |
| Mr. Hannes Reichl | MD of Impatient & Social Care and Member of the Management Board | 1976 |
| Dr. Eckart Pech | MD of Consumer & Health Management Information Systems and Member of the Management Board | 1969 |
| Mr. Emanuele Mugnani | MD of Ambulatory Information Systems Europe & Member of Management Board | 1970 |
| Ms. Angela Mazza Teufer | MD of Ambulatory Information Systems DACH, Connectivity & CLICKDOC & Member of Management Board | 1973 |
| Ms. Claudia Thomé | Corp. VP of Investor Relations | 1971 |
| Alexander Weimer | Head of Corp. & Co-Head of Brand Communications | NA |
| Mr. Oliver Bruzek | Chief Communication Officer of Political & Public Affairs | NA |
| Michael Franz | Co- Head of Brand Communication | NA |
| Mr. Helge Weiß | Sr. VP of Connectivity | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...